Latest News & Features
Big Pharma
An “active regulatory partnership” between the UK and the EU is necessary to ensure patients have “timely access” to medicines post-Brexit, according to the UK’s Medicines and Healthcare Products Regulatory Agency. 30 April 2018
Americas
The Federal Trade Commission is requiring Impax to divest rights and assets for ten products, as part of a settlement resolving charges that Amneal’s $1.45 billion acquisition would be anti-competitive. 30 April 2018
Americas
The Patents 4 Patients programme has received a modest amount of activity since it started two years ago, according to Mary Till, senior legal advisor at the US Patent and Trademark Office. 27 April 2018
Americas
Barnes & Thornburg has welcomed David Kelly as a partner to its IP department. 27 April 2018
Americas
Panellists discussing global patent enforceability at the Life Sciences Patent Network North America event have expressed optimism over the Unified Patent Court (UPC), despite uncertainty about its implementation. 26 April 2018
Americas
The US Court of Appeals for the Federal Circuit has affirmed a finding that pharmaceutical company Merck had engaged in misconduct and was not allowed to bring an action against Gilead. 26 April 2018
Asia-Pacific
China’s State Intellectual Property Office has granted Merck KGaA a patent covering its CRISPR technology used in a genomic-integration method for eukaryotic cells. 26 April 2018
Big Pharma
Advocate General Melchior Wathelet has advised the Court of Justice of the European Union on a case involving a supplementary protection certificate. 25 April 2018
Europe
Genomic Health, a California-based company that focuses on genetic research in cancer detection, has failed to overturn a trademark decision in Europe. 24 April 2018